Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01975701
Title A Phase 2 Study of BGJ398 in Patients With Recurrent GBM
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

glioblastoma

Therapies

Infigratinib

Age Groups: adult
Covered Countries USA | ESP | BEL

Additional content available in CKB BOOST